Early data from first participating employer show that SmartRx can save organizations millions by bypassing traditional PBMs to deliver brand-name GLP-1 medications NEW YOR K, April 23, 2026 Noom Health, the enterprise division of the leading behavior change platform Noom, today announced that its Smart Rx program is on pace to cut GLP-1 medication costs by nearly 80% for its first participating employer, projecting approximately $1.3M in annual spend compared to $6.2M in the prior year
Allergy to sitagliptin or any inactive ingredient Severe kidney disease or dialysis History of heart failure or pancreatitis Alcohol use, gallstones, high triglycerides Pregnancy or plans to become pregnant Breastfeeding or plans to breastfeed What drug interactions are there with Januvia
10.1210/clinem/dgab905 32 LingvayI.BauerR.Baker-KnightJ.LawsonJ.PratleyR
Reed G, Galindo MA
Blood testing may be recommended to assess Cholesterol, Blood glucose levels, Albumin, Thyroid function etc
"Fortunately, once the prescriber completes prior authorization for the drug, the program uses routine pharmacy processes," said Lisa Schwartz, senior director of professional affairs at the National Community Pharmacists Association
